Spirit Scientific Co., Ltd. (TPEX:7790)

Taiwan · Delayed Price · Currency is TWD

48.20

0.00 (0.00%)

At close: Aug 18, 2026

-37.75% (1Y)

Market Cap	895.78M -37.0%
Revenue (ttm)	273.29M +20.7%
Net Income	20.06M +297.0%
EPS	1.08 +276.7%
Shares Out	18.58M
PE Ratio	44.79
Forward PE	n/a
Dividend	0.57 (1.20%)
Ex-Dividend Date	Jul 13, 2026

Volume	5
Open	48.20
Previous Close	48.20
Day's Range	48.20 - 48.20
52-Week Range	42.76 - 83.14
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 24, 2026

About Spirit Scientific

Spirit Scientific Co., Ltd. engages in the production and sale of growth factor jelly-related products. The company offers Platelet Lyophilized Treatment (PLT), a high-concentration platelet therapy derived from autologous blood; PLT Hydraglow, a hydrogel lyophilization combined with a hyaluronic acid hydrating essence, serves as a post-treatment care system for damaged skin; PLTgel; and PLT-AE. It also provides lyophilized biomaterial testing and CDMO services; biomaterial-based raw material production services; and integrated packaging and de... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 2015

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7790

Full Company Profile

Financial Performance

In 2025, Spirit Scientific's revenue was 273.29 million, an increase of 20.71% compared to the previous year's 226.39 million. Earnings were 20.06 million, an increase of 296.99%.

Financial Statements